Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	serine-type endopeptidase activity	PRSS55 TPSAB1 DPP4 CTRL PRSS41 CTSV ST14 TPSB2 PRSS21	6.79e-11	190	38	9	GO:0004252
GeneOntologyMolecularFunction	serine-type peptidase activity	PRSS55 TPSAB1 DPP4 CTRL PRSS41 CTSV ST14 TPSB2 PRSS21	1.46e-10	207	38	9	GO:0008236
GeneOntologyMolecularFunction	serine hydrolase activity	PRSS55 TPSAB1 DPP4 CTRL PRSS41 CTSV ST14 TPSB2 PRSS21	1.81e-10	212	38	9	GO:0017171
GeneOntologyMolecularFunction	endopeptidase activity	PRSS55 TPSAB1 DPP4 CTRL PRSS41 CTSV ST14 TPSB2 PRSS21	8.59e-08	430	38	9	GO:0004175
GeneOntologyMolecularFunction	peptidase activity	PRSS55 TPSAB1 DPP4 CTRL PRSS41 CTSV ST14 TPSB2 PRSS21	2.86e-06	654	38	9	GO:0008233
GeneOntologyMolecularFunction	beta-galactosidase activity	GLB1 GLB1L	3.51e-05	5	38	2	GO:0004565
GeneOntologyMolecularFunction	galactosidase activity	GLB1 GLB1L	7.36e-05	7	38	2	GO:0015925
GeneOntologyMolecularFunction	cysteine-type endopeptidase activator activity involved in apoptotic process	CTSV APAF1	1.39e-03	29	38	2	GO:0008656
GeneOntologyMolecularFunction	peptidase activator activity involved in apoptotic process	CTSV APAF1	1.69e-03	32	38	2	GO:0016505
Domain	TRYPSIN_SER	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	3.55e-10	90	36	7	IPR033116
Domain	TRYPSIN_HIS	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	9.24e-10	103	36	7	IPR018114
Domain	TRYPSIN_SER	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	1.13e-09	106	36	7	PS00135
Domain	TRYPSIN_HIS	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	1.21e-09	107	36	7	PS00134
Domain	Peptidase_S1A	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	1.78e-09	113	36	7	IPR001314
Domain	TRYPSIN_DOM	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	2.01e-09	115	36	7	PS50240
Domain	Tryp_SPc	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	2.27e-09	117	36	7	SM00020
Domain	Trypsin	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	2.87e-09	121	36	7	PF00089
Domain	Trypsin_dom	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	2.87e-09	121	36	7	IPR001254
Domain	Peptidase_S1_PA	PRSS55 TPSAB1 CTRL PRSS41 ST14 TPSB2 PRSS21	3.22e-09	123	36	7	IPR009003
Domain	Galactose-bd-like	CNTNAP3 CNTNAP4 CNTNAP3B HERC2 GLB1 GLB1L	2.38e-08	94	36	6	IPR008979
Domain	-	CNTNAP3 CNTNAP4 HERC2 GLB1 GLB1L	2.72e-07	73	36	5	2.60.120.260
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP3 CNTNAP4 CNTNAP3B FGL2	4.02e-07	32	36	4	IPR002181
Domain	FIBRINOGEN_C_2	CNTNAP3 CNTNAP4 CNTNAP3B FGL2	4.02e-07	32	36	4	PS51406
Domain	FIBRINOGEN_C_1	CNTNAP3 CNTNAP4 CNTNAP3B FGL2	4.02e-07	32	36	4	PS00514
Domain	FA58C	CNTNAP3 CNTNAP4 CNTNAP3B	8.54e-06	21	36	3	SM00231
Domain	FA58C_3	CNTNAP3 CNTNAP4 CNTNAP3B	8.54e-06	21	36	3	PS50022
Domain	FA58C_1	CNTNAP3 CNTNAP4 CNTNAP3B	8.54e-06	21	36	3	PS01285
Domain	FA58C_2	CNTNAP3 CNTNAP4 CNTNAP3B	8.54e-06	21	36	3	PS01286
Domain	F5_F8_type_C	CNTNAP3 CNTNAP4 CNTNAP3B	1.29e-05	24	36	3	PF00754
Domain	FA58C	CNTNAP3 CNTNAP4 CNTNAP3B	1.29e-05	24	36	3	IPR000421
Domain	B-gal_1-like	GLB1 GLB1L	2.16e-05	4	36	2	IPR026283
Domain	GLYCOSYL_HYDROL_F35	GLB1 GLB1L	2.16e-05	4	36	2	PS01182
Domain	Glyco_hydro_35	GLB1 GLB1L	2.16e-05	4	36	2	PF01301
Domain	Gly_Hdrlase_35_cat	GLB1 GLB1L	2.16e-05	4	36	2	IPR031330
Domain	Glycoside_Hdrlase_35	GLB1 GLB1L	2.16e-05	4	36	2	IPR001944
Domain	FBG	CNTNAP3 CNTNAP4 FGL2	2.32e-05	29	36	3	SM00186
Domain	-	CNTNAP3 CNTNAP4 FGL2	2.58e-05	30	36	3	3.90.215.10
Domain	Fibrinogen_a/b/g_C_1	CNTNAP3 CNTNAP4 FGL2	2.58e-05	30	36	3	IPR014716
Domain	LAM_G_DOMAIN	CNTNAP3 CNTNAP4 CNTNAP3B	5.30e-05	38	36	3	PS50025
Domain	Laminin_G_2	CNTNAP3 CNTNAP4 CNTNAP3B	6.19e-05	40	36	3	PF02210
Domain	LamG	CNTNAP3 CNTNAP4 CNTNAP3B	8.25e-05	44	36	3	SM00282
Domain	Laminin_G	CNTNAP3 CNTNAP4 CNTNAP3B	1.89e-04	58	36	3	IPR001791
Domain	ConA-like_dom	CNTNAP3 CNTNAP4 CNTNAP3B TRIM7	8.07e-04	219	36	4	IPR013320
Domain	-	GLB1 GLB1L	2.07e-03	35	36	2	3.20.20.80
Domain	Glyco_hydro_catalytic_dom	GLB1 GLB1L	2.43e-03	38	36	2	IPR013781
Domain	SH3_1	NEB SH3PXD2A SKAP1	3.84e-03	164	36	3	PF00018
Domain	Glycoside_hydrolase_SF	GLB1 GLB1L	4.68e-03	53	36	2	IPR017853
Domain	SH3	NEB SH3PXD2A SKAP1	8.22e-03	216	36	3	PS50002
Domain	SH3	NEB SH3PXD2A SKAP1	8.22e-03	216	36	3	SM00326
Domain	SH3_domain	NEB SH3PXD2A SKAP1	8.65e-03	220	36	3	IPR001452
Domain	EGF_3	CNTNAP3 CNTNAP4 CNTNAP3B	1.03e-02	235	36	3	PS50026
Domain	EGF	CNTNAP3 CNTNAP4 CNTNAP3B	1.03e-02	235	36	3	SM00181
Domain	EGF-like_dom	CNTNAP3 CNTNAP4 CNTNAP3B	1.21e-02	249	36	3	IPR000742
Domain	EGF_1	CNTNAP3 CNTNAP4 CNTNAP3B	1.29e-02	255	36	3	PS00022
Pubmed	Mouse chromosome 17A3.3 contains 13 genes that encode functional tryptic-like serine proteases with distinct tissue and cell expression patterns.	TPSAB1 PRSS41 PRSS21	1.44e-07	10	38	3	14583634
Pubmed	Cell adhesion molecule contactin-associated protein 3 is expressed in the mouse basal ganglia during early postnatal stages.	CNTNAP3 CNTNAP4 CNTNAP3B	8.10e-07	17	38	3	26389685
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3 CNTNAP3B	1.16e-06	2	38	2	31150793
Pubmed	The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.	TPSAB1 TPSB2	1.16e-06	2	38	2	10500112
Pubmed	Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.	TPSAB1 TPSB2	1.16e-06	2	38	2	8434231
Pubmed	Cloning and characterization of a second complementary DNA for human tryptase.	TPSAB1 TPSB2	1.16e-06	2	38	2	2203827
Pubmed	Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.	TPSAB1 TPSB2	1.16e-06	2	38	2	10898108
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3 CNTNAP3B	1.16e-06	2	38	2	26807827
Pubmed	Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.	TPSAB1 TPSB2	1.16e-06	2	38	2	9521329
Pubmed	Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.	TPSAB1 TPSB2	1.16e-06	2	38	2	2187193
Pubmed	Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.	TPSAB1 TPSB2	1.16e-06	2	38	2	15567416
Pubmed	Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.	TPSAB1 TPSB2	1.16e-06	2	38	2	10391906
Pubmed	The human mast cell tryptase tetramer: a fascinating riddle solved by structure.	TPSAB1 TPSB2	1.16e-06	2	38	2	10708850
Pubmed	Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.	TPSAB1 TPSB2	1.16e-06	2	38	2	17449330
Pubmed	Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia.	TPSAB1 TPSB2	1.16e-06	2	38	2	31337736
Pubmed	Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.	TPSAB1 TPSB2	3.48e-06	3	38	2	9920877
Pubmed	Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype.	HERC2 BRCA1	3.48e-06	3	38	2	27759030
Pubmed	TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.	HERC2 BRCA1	3.48e-06	3	38	2	25480944
Pubmed	Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.	TPSAB1 TPSB2	3.48e-06	3	38	2	19748655
Pubmed	HERC2 is an E3 ligase that targets BRCA1 for degradation.	HERC2 BRCA1	3.48e-06	3	38	2	20631078
Pubmed	Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with PDZ domains.	CNTNAP3 CNTNAP4	1.16e-05	5	38	2	12093160
Pubmed	Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.	TPSAB1 TPSB2	1.16e-05	5	38	2	10843716
Pubmed	Large-scale investigation of genomic markers for severe periodontitis.	DPP4 FGL2	1.16e-05	5	38	2	15490304
Pubmed	Nucleolar exit of RNF8 and BRCA1 in response to DNA damage.	HERC2 BRCA1	1.16e-05	5	38	2	22814251
Pubmed	New developments in the genetics and activation of mast cell proteases.	TPSAB1 TPSB2	1.74e-05	6	38	2	12217407
Pubmed	In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development.	CNTNAP3 CNTNAP3B	1.74e-05	6	38	2	34143959
Pubmed	Activity-dependent and graded BACE1 expression in the olfactory epithelium is mediated by the retinoic acid metabolizing enzyme CYP26B1.	KIRREL2 ADCY3	3.24e-05	8	38	2	24797530
Pubmed	Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment.	SLC6A1 NFASC	4.16e-05	9	38	2	15479642
Pubmed	Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.	SLC6A1 CNTNAP4 ACSBG1 CTSV PTPRZ1	5.38e-05	376	38	5	24154525
Pubmed	Cloning and chromosomal mapping of mouse ADAM11, ADAM22 and ADAM23.	BRCA1 FGL2	9.00e-05	13	38	2	10433968
Pubmed	β3GnT2 maintains adenylyl cyclase-3 signaling and axon guidance molecule expression in the olfactory epithelium.	KIRREL2 ADCY3	1.05e-04	14	38	2	21525298
Pubmed	Olig2 regulates terminal differentiation and maturation of peripheral olfactory sensory neurons.	KIRREL2 ADCY3	1.76e-04	18	38	2	31758234
Pubmed	Local protease signaling contributes to neural tube closure in the mouse embryo.	CTRL ST14	2.18e-04	20	38	2	20152175
Pubmed	Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.	CTRL ST14	2.41e-04	21	38	2	19592578
Pubmed	Uncx regulates proliferation of neural progenitor cells and neuronal survival in the olfactory epithelium.	KIRREL2 ADCY3	2.41e-04	21	38	2	20692344
Pubmed	FoxP1 orchestration of ASD-relevant signaling pathways in the striatum.	CNTNAP3 CNTNAP3B	2.65e-04	22	38	2	26494785
Pubmed	Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.	NFASC HERC2	4.01e-04	27	38	2	34709416
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	TPSAB1 NFASC BRCA1 TPSB2	4.50e-04	329	38	4	17474147
Pubmed	Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons.	CNTNAP3 CNTNAP3B	4.63e-04	29	38	2	31491374
Pubmed	HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.	HERC2 BRCA1	5.30e-04	31	38	2	30279242
Pubmed	Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.	GLB1 B3GAT2	5.65e-04	32	38	2	17883393
Pubmed	Goofy coordinates the acuity of olfactory signaling.	KIRREL2 ADCY3	6.38e-04	34	38	2	23926254
Pubmed	Role of ADTRP (Androgen-Dependent Tissue Factor Pathway Inhibitor Regulating Protein) in Vascular Development and Function.	TPSAB1 DPP4	7.15e-04	36	38	2	30571485
Pubmed	Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice.	DPP4 SLC9A2	9.28e-04	41	38	2	23676500
Cytoband	16p13.3	TPSAB1 PRSS41 TPSB2 PRSS21	4.99e-05	244	38	4	16p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	TPSAB1 PRSS41 TPSB2 PRSS21	4.20e-04	426	38	4	chr16p13
GeneFamily	Proteases, serine	PRSS55 PRSS41 ST14 PRSS21	1.60e-06	63	25	4	738
GeneFamily	Solute carriers	SLC6A1 SLC8A2 SLC9A2	1.67e-02	395	25	3	752
GeneFamily	Fibronectin type III domain containing	NFASC PTPRZ1	2.04e-02	160	25	2	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NFASC KIRREL2	2.07e-02	161	25	2	593
Coexpression	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP	NEB ACSBG1 CTSV SH3PXD2A FGL2	1.01e-05	200	38	5	M4332
Coexpression	DESCARTES_ORGANOGENESIS_INHIBITORY_INTERNEURONS	CNTNAP3 SLC6A1 CNTNAP3B	1.11e-05	30	38	3	MM3663
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000	ERVH48-1 SLC8A2 PMEL KIRREL2 ACSBG1 CTSV PTPRZ1 ST14 B3GAT2	3.10e-05	993	36	9	PCBC_SC_blastocyst_1000
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#3	TPSAB1 ACSBG1 TPSB2	7.34e-05	48	36	3	Arv_SC_fibroblast_1000_K3
CoexpressionAtlas	geo_heart_top-relative-expression-ranked_500_k-means-cluster#5	TPSAB1 TPSB2	7.78e-05	8	36	2	geo_heart_500_K5
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#5	TPSAB1 ACSBG1 TPSB2	8.30e-05	50	36	3	Arv_SC-HD_1000_K5
CoexpressionAtlas	DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#4_top-relative-expression-ranked_200	DPP4 GLB1L TRIM7	8.81e-05	51	36	3	gudmap_developingKidney_e15.5_Proximal Tubules_200_k4
CoexpressionAtlas	alpha beta T cells, T.4.Sp.B16, 4+ 8- TCR+ 45+, B16 Melanoma Spleen, avg-2	PMEL NEB ACSBG1 SKAP1 FGL2	1.99e-04	322	36	5	GSM605761_500
CoexpressionAtlas	alpha beta T cells, T.4.Sp.B16, 4+ 8- TCR+ 45+, B16 Melanoma Spleen, avg-2	NEB SKAP1 FGL2	2.27e-04	70	36	3	GSM605761_100
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 PRSS55 CNTNAP4 CNTNAP3B DPP4	4.37e-07	180	38	5	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Suprabasal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SLC6A1 SLC9A2 CTSV PTPRZ1 ST14	7.36e-07	200	38	5	924eacea513dde8e3bd805a335bc4285647b800d
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-CD45____NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 ACSBG1 SKAP1 FGL2	1.11e-05	163	38	4	a763c1632d6465a1e753bdc8eadaf819d2b09e5e
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 ACSBG1 SKAP1 FGL2	1.11e-05	163	38	4	eaed783eecd07aafa5af844b63c9d816b4da99e4
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEB ACSBG1 PRSS41 SKAP1	1.22e-05	167	38	4	eed22d1a17aab84dacb1a488528bae9389644cb9
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEB PRSS41 SKAP1 FGL2	1.25e-05	168	38	4	c09aa66fd1374ecc4b4d4b56600a6f04aafa5be9
ToppCell	Myeloid-Myeloid-D_(Mast_cell)\|Myeloid / shred on cell class and cell subclass (v4)	TPSAB1 ST14 TPSB2 SKAP1	1.34e-05	171	38	4	5f1aafc4c55a9c6c3153430186a8a351425a3cb9
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB ACSBG1 PRSS41 SKAP1	1.34e-05	171	38	4	8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB ACSBG1 PRSS41 SKAP1	1.34e-05	171	38	4	f4cdd7862c8fe99ee765a2f3ed375b584f4976c5
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TPSAB1 IGHV1-58 TPSB2 SKAP1	1.41e-05	173	38	4	1e4afa020fae682521335b440ccd33c16f37156f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B B3GAT2	1.41e-05	173	38	4	61907116a1460bc157ba73b5edd108db7dd5de4b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TPSAB1 SLC9A2 PTPRZ1	1.47e-05	175	38	4	9d09636a103daa8f622c3dbfd1f1536aaec3b6bb
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B DPP4	1.54e-05	177	38	4	91706bd0d4dda8d98843fb00b898d5aca4d66b64
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B B3GAT2	1.61e-05	179	38	4	3b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B B3GAT2	1.68e-05	181	38	4	7704f236831cffe4f2a75d4c461eb88b4177e206
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B B3GAT2	1.68e-05	181	38	4	153709b4dd3d81e09f251fa8765b58bed1932fda
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 PRSS55 CNTNAP4 CNTNAP3B	1.72e-05	182	38	4	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 PRSS55 CNTNAP4 CNTNAP3B	1.72e-05	182	38	4	05c167158815bf25d509df59ab386e1990712765
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B SLC9A2	1.79e-05	184	38	4	23515c28e1f42aab29cef9e5b4a7f45bda7f5520
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	1.91e-05	187	38	4	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Undetermined\|Myeloid_cells / Location, Cell class and cell subclass	TPSAB1 KIRREL2 TPSB2 SKAP1	1.99e-05	189	38	4	b46adb47768a7b6d801c457d7ba65508edfc36a5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 SLC9A2 B3GAT2	1.99e-05	189	38	4	06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B SLC9A2	2.03e-05	190	38	4	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.03e-05	190	38	4	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 KIRREL2 ACSBG1 PTPRZ1	2.08e-05	191	38	4	fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A1 NFASC SH3PXD2A ADCY3	2.08e-05	191	38	4	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 KIRREL2 ACSBG1 PTPRZ1	2.12e-05	192	38	4	d2161842a38146261847fc9061ba9322e0f087e0
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B SLC9A2	2.16e-05	193	38	4	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 SLC9A2 B3GAT2	2.16e-05	193	38	4	2c15186d15545804cc262da9137ab825609d4b2c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B B3GAT2	2.16e-05	193	38	4	8b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 SLC6A1 CNTNAP3B SLC9A2	2.21e-05	194	38	4	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	distal-2-Hematologic-Basophil/Mast_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TPSAB1 DPP4 TPSB2 SKAP1	2.30e-05	196	38	4	ad21706a281f0b105eb3979e3e47fe0cec6c527f
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLC6A1 NFASC ADCY3 B3GAT2	2.39e-05	198	38	4	0dc5806714fb3d3983e9d19fa7a108e93a8090ed
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.48e-05	200	38	4	4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.48e-05	200	38	4	1276bfa911fddada4235e12e3081baa53164574b
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.48e-05	200	38	4	5ec469267747dce3601c1d8ad01af89fa5b29acc
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.48e-05	200	38	4	e79d93d55b25804f2608185168da472301b6ebca
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.48e-05	200	38	4	fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.48e-05	200	38	4	c6eda342ea0cb37d71d89dbb8d11e819e0745172
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 SLC6A1 CNTNAP3B PTPRZ1	2.48e-05	200	38	4	320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P2\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	5.05e-05	84	38	3	1f8b19b159f83655f66cb99f8d10d9a87c08f78f
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	5.05e-05	84	38	3	c37e1170d39ad015f724e373a547ea5b6ba45a84
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	5.05e-05	84	38	3	7e4a76b65b0d34d9950f8b02590ff5a4b4534a27
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	5.05e-05	84	38	3	503490e9408d9638bcd089ef8ec0521924df9a5d
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	6.21e-05	90	38	3	6adc78899a08d48da8ed4618ecf866c9ed9be059
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	6.21e-05	90	38	3	a74f8172780adc1410e36e2718412010ee0ebf1f
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	6.21e-05	90	38	3	909ad62d175b657d8e541b0981ce8fed0ba7ed6c
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE-P2\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PMEL BRCA1 ST14	6.21e-05	90	38	3	936c5078677ec934f3049d8aa5a14d930aa2e6dc
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PRSS55 CNTNAP4 SLC8A2	1.68e-04	126	38	3	a1ea8cf6b444a640544d204dfaf5ff219dc31aa9
ToppCell	Myeloid-D_(Mast_cell)\|World / shred on cell class and cell subclass (v4)	TPSAB1 TPSB2 SKAP1	1.85e-04	130	38	3	574e262eb4ed2d69c3da68be061cebac9fefc29e
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRZ1 B3GAT2 TRIM7	2.11e-04	136	38	3	186be8e1595608004b8216892cb9c7a7f31fbb4d
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CNTNAP4 DPP4 SKAP1	2.20e-04	138	38	3	b63e26afafbd2cdeed9c9451e6f530ab6295504c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B SLC9A2 BRCA1	2.25e-04	139	38	3	c9bf98bed77415a1438f3f9e441a1346e75c26b0
ToppCell	Lymphoid-T_cells_(Cd8+_T_cell)\|World / shred on cell class and cell subclass (v4)	PRSS41 SKAP1 FGL2	2.25e-04	139	38	3	c85f50fb536f4df6fa4dbdebe48e1ecea1df1121
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-iNKT-MAIT\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP4 GLB1L SKAP1	2.30e-04	140	38	3	a8f3b01d03ee0bf0e752327a98d6b9035930c2b0
ToppCell	LPS-IL1RA-Hematopoietic_Mast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP4 ACSBG1 SKAP1	2.39e-04	142	38	3	f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992
ToppCell	LPS-IL1RA-Hematopoietic_Mast-Mast_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP4 ACSBG1 SKAP1	2.39e-04	142	38	3	2a9a070e7c53ac593d46c6c5f6983f07d4413501
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSBG1 SKAP1 FGL2	2.50e-04	144	38	3	46177f0d6117e701bda86a99ac2a1b0e7ed66177
ToppCell	Children_(3_yrs)-Immune-mast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TPSAB1 TPSB2 SKAP1	2.60e-04	146	38	3	f7349d63bb47f1f22ced8ff514edc1c11bc782e7
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	NFASC PMEL BRCA1	2.60e-04	146	38	3	a317f14a1aab11ffcce65baeb1c475c04324315f
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP4 ACSBG1 SKAP1	2.76e-04	149	38	3	59aa1f2a5cbeba64c4529fb05f544db17fd8b188
ToppCell	LPS-antiTNF-Hematopoietic_Mast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP4 ACSBG1 SKAP1	2.76e-04	149	38	3	1527cdd98a2734cbf8ce4c6170557280b71c55cb
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP4 ACSBG1 SKAP1	2.81e-04	150	38	3	7290e9a812b1b2f919e67ccde0acf52687ab138f
ToppCell	LPS_only-Hematopoietic_Mast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP4 ACSBG1 SKAP1	2.81e-04	150	38	3	2c5078a1f769ba8153dee756b53d28eb7b434a96
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CNTNAP3 CNTNAP4 B3GAT2	2.87e-04	151	38	3	090b067873740c282865e2d02cf47d5cb3dd7607
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DPP4 ACSBG1 SKAP1	2.92e-04	152	38	3	669d8f12fdb110ed72f4e5348b7b5350144a061c
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 TPSB2 SKAP1	2.92e-04	152	38	3	321d322d58c12fd752de4e8ea873f3f367302813
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 TPSB2 SKAP1	2.92e-04	152	38	3	a4d50e9af02231c5573aee905cf0905391e6da34
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC KIRREL2 CTSV	2.98e-04	153	38	3	c1335e7d7407412431ed4d8c7dfcb2c6086d8483
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL2 ACSBG1 PTPRZ1	2.98e-04	153	38	3	95b28c5bd10ffb74c0993ebd565038b9818e4bd2
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL2 ACSBG1 PTPRZ1	2.98e-04	153	38	3	b09f8def40a1ea56722f3398f61a036667b61cd9
ToppCell	Children_(3_yrs)-Immune-mast_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TPSAB1 TPSB2 SKAP1	2.98e-04	153	38	3	d3fb83ca984c7583b1e51c364be6c7c17f67b048
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KIRREL2 ACSBG1 PTPRZ1	2.98e-04	153	38	3	3ab9d55b3db51715c1d61eca142384195ce4b54f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CTSV B3GAT2 TPSB2	3.04e-04	154	38	3	1899138c096c08d8aee6b1970b7c0081e14c88a8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERVH48-1 SLC6A1 PTPRZ1	3.04e-04	154	38	3	30cb4bb297fa815adb829f3b5cafca56fcbcb810
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERVH48-1 SLC6A1 PTPRZ1	3.04e-04	154	38	3	ade094e2947761a0a34daa8fcff3e9ea8437e4a5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A1 SH3PXD2A ADCY3	3.04e-04	154	38	3	b6e982e341c6cfb6ff80a318078fcb10c36d182f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERVH48-1 SLC6A1 PTPRZ1	3.04e-04	154	38	3	42bd8f88fd075a2d4edde394785decad88a2660a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERVH48-1 SLC6A1 PTPRZ1	3.04e-04	154	38	3	6425d9861148586466febd6eceae1b1f9b9a14c1
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A2 SKAP1 FGL2	3.04e-04	154	38	3	75eac6970259a6916fcfa6d3400509cfa2d98d9d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A1 SH3PXD2A ADCY3	3.04e-04	154	38	3	d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSBG1 SKAP1 FGL2	3.04e-04	154	38	3	d0a1ff02a7e91f6923aa85b65094f78e357e377d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 ADCY3 TPSB2	3.10e-04	155	38	3	51f6447945389649d99dcf7603b396195c631ead
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSBG1 SKAP1 FGL2	3.10e-04	155	38	3	d8e9f355ce933f6383c3d1e35ff55235a95c7fcd
ToppCell	Adult-Immune-mast_cell-D122\|Adult / Lineage, Cell type, age group and donor	TPSAB1 TPSB2 SKAP1	3.10e-04	155	38	3	7c9de0591d1bf756b8e268b278bbe10bd5415dcd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 ADCY3 TPSB2	3.10e-04	155	38	3	23dc71cab28094ca0ac4d2baf4e24871ed107781
ToppCell	COVID-19-Mast_cells-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	TPSAB1 TPSB2 SKAP1	3.16e-04	156	38	3	bc10b94673184ef384c6665b16a1209a8975a4f1
ToppCell	10x5'v1-week_12-13-Myeloid_DC-DC-DC2\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SLC9A2 CTSV FGL2	3.16e-04	156	38	3	03f3c5ffb27758fe63797143fcc938f9e8a4e10d
ToppCell	COVID-19-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	TPSAB1 TPSB2 SKAP1	3.16e-04	156	38	3	159504d43421ee83b9ab484816333ae549c9c2fd
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	NFASC ST14 FGL2	3.21e-04	157	38	3	6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CNTNAP3 SLC6A1 CNTNAP4	3.21e-04	157	38	3	741d79c10cb87fa7f14080c6fccb1553c3a20bad
ToppCell	Adult-Immune-mast_cell-D231\|Adult / Lineage, Cell type, age group and donor	TPSAB1 TPSB2 SKAP1	3.21e-04	157	38	3	4c63bb91f8708644e6ce2500072a4eeb8e1079dd
ToppCell	Children_(3_yrs)-Immune-mast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TPSAB1 TPSB2 SKAP1	3.21e-04	157	38	3	ec185dbeabb67fd9ca85f71cab88463b60f9b1c1
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSBG1 SKAP1 FGL2	3.28e-04	158	38	3	5d926be5a0ebe8257cd552afa7844171f9ff01c0
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC6A1 TPSAB1 TPSB2	3.34e-04	159	38	3	ecd1daa33549541aee3bf4e139ab6732efc8e74c
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC6A1 TPSAB1 TPSB2	3.34e-04	159	38	3	7b6370c9567da7d40541c6e243efa704ed7e90ae
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSBG1 SKAP1 FGL2	3.34e-04	159	38	3	5c7a099aa84ecc62bf9b5e1609e5b6b77889f175
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPSAB1 TPSB2	3.39e-04	32	38	2	b2d87153b4aefefd7b5e31ea67aa43e5f599e734
ToppCell	TCGA-Pancreas-Primary_Tumor\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPSAB1 TPSB2	3.39e-04	32	38	2	f5bcaacbddfb85439ebf5908762bf39cb72b727c
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACSBG1 SKAP1 FGL2	3.40e-04	160	38	3	b2d8940ea8c068273b7da1589d3d6ae5110d8209
Drug	benzamidine	TPSAB1 CTRL ST14 TPSB2 FGL2 PRSS21	1.29e-07	147	37	6	CID000002332
Drug	butter yellow	TPSAB1 DPP4 GLB1 TPSB2	1.57e-07	30	37	4	CID000007340
Drug	Leupeptin hydrochloride	TPSAB1 GLB1 CTRL CTSV ST14 TPSB2 PRSS21	2.69e-07	276	37	7	CID000003910
Drug	AC1NUP69	TPSAB1 CTRL TPSB2	4.70e-07	10	37	3	CID005487154
Drug	Z-ala-ala-lys-mna	TPSAB1 CTRL TPSB2	6.46e-07	11	37	3	CID005486901
Drug	APMSF	TPSAB1 CTRL TPSB2 FGL2	1.09e-06	48	37	4	CID000001719
Drug	Z-ARR-AFC	TPSAB1 CTRL TPSB2	1.12e-06	13	37	3	CID000125067
Drug	Nk3201	TPSAB1 CTRL TPSB2	1.12e-06	13	37	3	CID000213050
Drug	pyridindolol	GLB1 GLB1L	2.57e-06	2	37	2	CID005358591
Drug	phenylmethylsulfonyl fluoride	TPSAB1 CTRL CTSV ST14 TPSB2 FGL2	3.86e-06	263	37	6	CID000004784
Drug	TLCK	TPSAB1 CTRL ADCY3 TPSB2 FGL2	5.50e-06	158	37	5	CID000004427
Drug	AC1NRA23	TPSAB1 CTRL CTSV TPSB2	5.93e-06	73	37	4	CID005287657
Drug	thymidine glycol monophosphate	TPSAB1 TPSB2	7.70e-06	3	37	2	CID000165415
Drug	AC1L8VEV	TPSAB1 ADCY3 TPSB2	7.81e-06	24	37	3	CID000433433
Drug	diisopropylfluorophosphate	TPSAB1 DPP4 CTRL ST14 TPSB2 FGL2	1.21e-05	321	37	6	CID000005936
Drug	AC1ND3F1	GLB1 GLB1L	1.54e-05	4	37	2	CID004568967
Drug	Brunfelsamidine	TPSAB1 TPSB2	1.54e-05	4	37	2	CID005281683
Drug	GPGR	TPSAB1 CTRL TPSB2	3.20e-05	38	37	3	CID000485268
Drug	2g6p	TPSAB1 ADCY3 TPSB2	3.20e-05	38	37	3	CID002740174
Drug	isocoumarin	TPSAB1 CTRL TPSB2	3.47e-05	39	37	3	CID000068108
Drug	NSC89634	TPSAB1 CTRL TPSB2	3.47e-05	39	37	3	CID000070877
Drug	DB04623	TPSAB1 TPSB2 PRSS21	3.47e-05	39	37	3	CID005459358
Drug	maltos	TPSAB1 GLB1 ACSBG1 GLB1L TPSB2 FGL2	3.76e-05	393	37	6	CID000000294
Drug	Attpsa	TPSAB1 TPSB2	3.84e-05	6	37	2	CID005487511
Drug	EHDA	BRCA1 GLB1	3.84e-05	6	37	2	CID006438592
Drug	Phe-pro-arg	TPSAB1 TPSB2 FGL2	4.04e-05	41	37	3	CID000133189
Drug	NPGB	TPSAB1 CTRL TPSB2	4.04e-05	41	37	3	CID000030744
Drug	UDP-glucose	TPSAB1 GLB1 B3GAT2 TPSB2 TRIM7	4.74e-05	247	37	5	CID000001166
Drug	ioxaglate	TPSAB1 TPSB2	5.37e-05	7	37	2	CID000003742
Drug	Telebrix	TPSAB1 TPSB2	5.37e-05	7	37	2	CID000034536
Drug	isobutyrate	TPSAB1 SLC9A2 TPSB2	7.80e-05	51	37	3	CID000006590
Drug	daphnodorin C	TPSAB1 TPSB2	9.18e-05	9	37	2	CID000072428
Drug	AC1LTNWX	TPSAB1 ADCY3 TPSB2	1.15e-04	58	37	3	CID001536427
Drug	1c5s	TPSAB1 TPSB2	1.15e-04	10	37	2	CID000444753
Drug	8-iso Misoprostol	KIRREL2 ADCY3 FGL2	1.40e-04	62	37	3	CID004183806
Drug	fenpropathrin	TPSAB1 TPSB2 FGL2	1.40e-04	62	37	3	CID000047326
Drug	hexopyranos-3-ulose	GLB1 GLB1L	1.40e-04	11	37	2	CID000000349
Drug	pimaradiene	TPSAB1 TPSB2	1.40e-04	11	37	2	CID000440909
Drug	daphnodorin A	TPSAB1 TPSB2	1.40e-04	11	37	2	CID000072426
Drug	AC1NSU64	TPSAB1 TPSB2	1.40e-04	11	37	2	CID005316303
Drug	methylhistamine	TPSAB1 TPSB2	1.40e-04	11	37	2	CID000000912
Drug	N-acetyllactosamine	GLB1 PTPRZ1 GLB1L B3GAT2	1.42e-04	164	37	4	CID000000245
Drug	sodium cromoglycate	TPSAB1 TPSB2 PRSS21	1.47e-04	63	37	3	CID000002881
Drug	AC1Q6PMP	TPSAB1 CTRL ST14 TPSB2	1.60e-04	169	37	4	CID000103535
Drug	bis(5-amidino-2-benzimidazolyl)methane	TPSAB1 TPSB2	1.68e-04	12	37	2	CID000002386
Drug	NSC-648146	TPSAB1 TPSB2	1.68e-04	12	37	2	CID000372649
Drug	Elocom	TPSAB1 TPSB2	1.68e-04	12	37	2	CID000123620
Drug	4-amidinophenylpyruvic acid	TPSAB1 TPSB2	1.68e-04	12	37	2	CID000151496
Drug	AC1MMOKY	GLB1 GLB1L	1.68e-04	12	37	2	CID003289210
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	PMEL ACSBG1 CTSV APAF1	1.75e-04	173	37	4	5594_UP
Drug	PCMB	GLB1 CTRL CTSV ADCY3	1.95e-04	178	37	4	CID000001730
Drug	Gly-pro-mca	DPP4 CTRL	1.98e-04	13	37	2	CID000125640
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	PMEL ACSBG1 CTSV APAF1	1.99e-04	179	37	4	5903_UP
Drug	ABPH	TPSAB1 TPSB2	2.31e-04	14	37	2	CID000092377
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	NEB CTRL ACSBG1 GLB1L	2.40e-04	188	37	4	2370_UP
Drug	nafamostat mesilate	TPSAB1 TPSB2 FGL2	2.66e-04	77	37	3	CID000004413
Drug	AC1L9K4M	TPSAB1 TPSB2	2.66e-04	15	37	2	CID000446820
Drug	FdTTP	TPSAB1 TPSB2	2.66e-04	15	37	2	CID000162005
Drug	chloromethyl	TPSAB1 CTRL TPSB2 FGL2	2.76e-04	195	37	4	CID000007835
Drug	Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; PC3; HT_HG-U133A	SLC9A2 SH3PXD2A GLB1L APAF1	2.82e-04	196	37	4	4479_UP
Drug	glutathionesulfonic acid	SLC6A1 PMEL PRSS21	2.87e-04	79	37	3	CID000003486
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A	PMEL CTRL GLB1L APAF1	2.87e-04	197	37	4	2455_UP
Drug	Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	SLC9A2 UQCR11 ADCY3 ST14	2.87e-04	197	37	4	5287_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	CTRL SH3PXD2A ST14 APAF1	2.87e-04	197	37	4	3133_DN
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A	DPP4 NEB GLB1L APAF1	2.87e-04	197	37	4	4077_UP
Drug	Cholecalciferol [67-97-0]; Up 200; 10.4uM; PC3; HT_HG-U133A	NEB CTRL SKAP1 APAF1	2.93e-04	198	37	4	6656_UP
Drug	Ungerine nitrate; Up 200; 10.2uM; HL60; HT_HG-U133A	ACSBG1 ST14 FGL2 APAF1	2.98e-04	199	37	4	2514_UP
Drug	TMOF	DPP4 CTRL	3.04e-04	16	37	2	CID005488810
Drug	BM 17.0744	GLB1 GLB1L	3.04e-04	16	37	2	CID009929731
Drug	5 alpha-androstan-3-one	TPSAB1 TPSB2	3.04e-04	16	37	2	CID000102028
Drug	(E)-4-aminohex-4-enoic acid	TPSAB1 TPSB2	3.04e-04	16	37	2	CID005288385
Drug	thymidine glycol	TPSAB1 TPSB2	3.04e-04	16	37	2	CID003035041
Drug	N-acetyl-S-farnesyl-L-cysteine	TPSAB1 DPP4 TPSB2	3.20e-04	82	37	3	CID000001994
Drug	AC1NRATE	SLC6A1 DPP4 GLB1	3.32e-04	83	37	3	CID005288086
Drug	DB07356	TPSAB1 DPP4 TPSB2	3.32e-04	83	37	3	CID011840917
Drug	4-methylumbelliferyl	GLB1 CTRL ADCY3	3.32e-04	83	37	3	CID000011833
Drug	77 B	PMEL GLB1	3.44e-04	17	37	2	CID005494400
Drug	l 8 h	DPP4 GLB1	3.44e-04	17	37	2	CID000151041
Drug	methylimidazoleacetic acid	TPSAB1 TPSB2	3.44e-04	17	37	2	CID000075810
Drug	H 17	TPSAB1 TPSB2	3.44e-04	17	37	2	CID000476867
Drug	azelaic bishydroxamic acid	GLB1 GLB1L	3.44e-04	17	37	2	CID000065268
Drug	l-alanyl-l-proline	TPSAB1 DPP4 TPSB2	3.81e-04	87	37	3	CID000083525
Drug	Fp-O	TPSAB1 DPP4 TPSB2	3.81e-04	87	37	3	CID000024267
Drug	2-azetidinone	TPSAB1 TPSB2	3.87e-04	18	37	2	CID000136721
Drug	AC1L3X9U	DPP4 FGL2	3.87e-04	18	37	2	CID000096811
Drug	neotrehalose	TPSAB1 GLB1 TPSB2 APAF1	3.93e-04	214	37	4	CID000001143
Drug	A80a	TPSAB1 TPSB2	4.79e-04	20	37	2	CID005487000
Drug	NSC49103	TPSAB1 TPSB2	4.79e-04	20	37	2	CID000005251
Drug	atracurium besylate	TPSAB1 TPSB2	5.82e-04	22	37	2	CID000047320
Drug	boronic acids	DPP4 CTRL	5.82e-04	22	37	2	CID000139619
Drug	1-deoxynojirimycin hydrochloride	PMEL GLB1 GLB1L	6.07e-04	102	37	3	CID000001374
Drug	C12063	SLC6A1 PMEL GLB1 FGL2 APAF1	6.15e-04	429	37	5	CID005282055
Drug	tryptophanyl-5'AMP	TPSAB1 TPSB2	6.36e-04	23	37	2	CID000446202
Drug	Ac-devd-amc	CTRL APAF1	6.36e-04	23	37	2	CID000001992
Drug	AC1L3W0F	ACSBG1 ST14	6.36e-04	23	37	2	CID000123172
Drug	Kinetensin	TPSAB1 TPSB2	6.36e-04	23	37	2	CID000147043
Drug	PL 0	TPSAB1 TPSB2	6.93e-04	24	37	2	CID000016157
Drug	Z-Phe-Phe-CHN2	DPP4 CTSV	6.93e-04	24	37	2	CID005486921
Drug	2-vinyl benzaldehyde	TPSAB1 CTRL TPSB2	7.17e-04	108	37	3	CID000039391
Drug	ethylnylestradiol	SLC6A1 BRCA1 GLB1 CTRL ACSBG1 ADCY3 FGL2 APAF1	7.52e-04	1251	37	8	CID000003285
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3 CNTNAP4 CNTNAP3B	8.53e-08	8	35	3	DOID:0060308 (implicated_via_orthology)
Disease	tryptase beta-2 measurement	TPSAB1 TPSB2	4.89e-05	9	35	2	EFO_0008306
Disease	Schizophrenia	SLC6A1 NFASC BRCA1 CTRL PTPRZ1 SH3PXD2A B3GAT2	6.78e-05	883	35	7	C0036341
Disease	brain ischemia (biomarker_via_orthology)	SLC8A2 CTSV APAF1	2.42e-04	102	35	3	DOID:2316 (biomarker_via_orthology)
Disease	urticaria	TPSAB1 TPSB2	2.56e-04	20	35	2	EFO_0005531
Disease	muscular atrophy (biomarker_via_orthology)	CTSV APAF1	5.44e-04	29	35	2	DOID:767 (biomarker_via_orthology)
Disease	ovarian carcinoma	SLC6A1 BRCA1 PTPRZ1 SKAP1	5.52e-04	321	35	4	EFO_0001075
Disease	temporal lobe epilepsy (biomarker_via_orthology)	SLC6A1 PTPRZ1	6.22e-04	31	35	2	DOID:3328 (biomarker_via_orthology)
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP3 CNTNAP4 CNTNAP3B	7.77e-04	152	35	3	DOID:0060041 (implicated_via_orthology)
Disease	Breast adenocarcinoma	HERC2 BRCA1	1.09e-03	41	35	2	C0858252
Disease	Neoplasm of uncertain or unknown behavior of breast	HERC2 BRCA1	1.09e-03	41	35	2	C0496956
Disease	forced expiratory volume	SLC6A1 SLC9A2 SH3PXD2A ADCY3 SKAP1	2.25e-03	789	35	5	EFO_0004314
Disease	basophil measurement	TPSAB1 TPSB2	2.32e-03	60	35	2	EFO_0803539
Disease	Contact hypersensitivity	TPSAB1 GLB1	3.23e-03	71	35	2	C0162351
Disease	Contact Dermatitis	TPSAB1 GLB1	3.23e-03	71	35	2	C0011616
Disease	Mental Depression	SLC6A1 DPP4 BRCA1	3.37e-03	254	35	3	C0011570
Disease	asthma, response to diisocyanate	NFASC HERC2 SH3PXD2A	3.63e-03	261	35	3	EFO_0006995, MONDO_0004979

Protein segments in the cluster

Peptide	Gene	Start	Entry
GGYIKWWNVVTGESS	APAF1	1196	O14727
QKGNTWVLIGIVSWG	CTRL	221	P40313
GAGGWTPLVSNKYQW	CNTNAP3	66	Q9BZ76
NSWGPEWGSNGYVKI	CTSV	301	O60911
GAGGWSPLVSNKYQW	CNTNAP4	66	Q9C0A0
NWVPTAYTWGAVGAV	UQCR11	16	O14957
AYTWGAVGAVGLVWA	UQCR11	21	O14957
WIGWIVVGSGNTNYA	IGHV1-58	66	A0A0C4DH39
SLQEVIGWGLIGWKY	HERC2	421	O95714
IGWGLIGWKYYANVI	HERC2	426	O95714
IQFPGWTKGQVWING	GLB1	571	P16278
WTKGQVWINGFNLGR	GLB1	576	P16278
PWVWGGVGTLLYQLG	PCNX4	51	Q63HM2
NKRIAIWGWSYGGYV	DPP4	621	P27487
IGWSYTGALNQKNWG	PTPRZ1	36	P23471
DKDGLWYQVGIVSWG	PRSS41	256	Q7RTY9
WNNVTVWGSRYVVGQ	NFASC	776	O94856
GIAGGKWVVSYFWVT	BRCA1	1706	P38398
IGTDLVQWIWGGYSV	MT-CYB	156	P00156
LVENGKVVGWYTGWR	B3GAT2	221	Q9NPZ5
LYLPGWTKGQVWING	GLB1L	556	Q6UWU2
WTKGQVWINGFNLGR	GLB1L	561	Q6UWU2
VWINGFNLGRYWTKQ	GLB1L	566	Q6UWU2
IAAQIYDLWTGIQWG	ACSBG1	331	Q96GR2
LGGVLGQKRWQYDVW	ADCY3	421	O60266
QKYRGVRNGIFWGTW	FGL2	396	Q14314
ALGAYWGLVQWTKSG	KIRREL2	46	Q6UWL6
GAGGWTPLVSNKYQW	CNTNAP3B	66	Q96NU0
LWPQGGGWVQQVALK	RXFP4	331	Q8TDU9
KVNGTWLQAGVVSWG	TPSAB1	231	Q15661
KVNGTWLQAGVVSWG	TPSB2	231	P20231
YFCIWKGVGWTGKVV	SLC6A1	226	P30531
NYVFPKWGQGVGWLM	SLC6A1	526	P30531
YVWKTWGQYWQVLGG	PMEL	151	P40967
WGQYWQVLGGPVSGL	PMEL	156	P40967
GVWALQLNGGQYWAV	TRIM7	431	Q9C029
IGTIFWYAVVGTLWN	SLC9A2	166	Q9UBY0
WYAVVGTLWNSIGIG	SLC9A2	171	Q9UBY0
NSGGWWYVQIGEKEG	SH3PXD2A	481	Q5TCZ1
AGKAIWVTGWGHTQY	ST14	741	Q9Y5Y6
GKQWLCFTKIGQWGV	ERVH48-1	106	M5A8F1
GEKWYQVGIISWGKS	PRSS55	261	Q6UWB4
ILGNGYIALVNWIDW	TAS2R8	21	Q9NYW2
KNGLWYQIGVVSWGV	PRSS21	246	Q9Y6M0
YGWWVGELNSLVGIV	SKAP1	331	Q86WV1
GVAWSVAAVYWAVQG	SLC8A2	831	Q9UPR5
YNNWMKGIGWIPIGS	NEB	1196	P20929